# Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants

> **NCT06648824** · PHASE1 · COMPLETED · sponsor: **Agios Pharmaceuticals, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Mitapivat
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT06648824
- **Lead sponsor:** Agios Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-17
- **Primary completion:** 2024-12-03
- **Final completion:** 2024-12-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06648824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06648824, "Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06648824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*